The integration of TrakCel’s OCELLOS and Lash Group’s Fusion aims to improve speed-to-therapy by increasing connectivity between providers and hub patient services Conshohocken, Pa. (January

Founded by an Experienced Management Team and Built on the Reach and Infrastructure of the San Diego Blood Bank   January 24, 2022  San Diego,

MARLBOROUGH, Mass. and MINNEAPOLIS, Jan. 05, 2022 (GLOBE NEWSWIRE) — Akoya Biosciences, Inc., (NASDAQ: AKYA), The Spatial Biology Company®, and Bio-Techne (NASDAQ: TECH), a global

SALT LAKE CITY, UTAH (December 14, 2021) – Carterra, Inc. the world leader in label-free high throughput antibody screening and characterization, today announced that it has

Partnership pairs Akoya’s spatial phenotyping solutions and PathAI’s AI-based algorithms to elucidate spatial biomarker signatures for biopharma partners MARLBOROUGH, Mass., Dec. 13, 2021 (GLOBE NEWSWIRE)

Funds will accelerate commercial activity and product development initiatives Durham, NC: Cell Microsystems Inc, a developer and manufacturer of innovative products for single cell workflows,

October 4, 2021 – Mountain View, California – FOR IMMEDIATE RELEASE Specific Diagnostics today announced it has signed multi-year reagent rental agreements with two clinical

LAKEWOOD, Colo., Sept. 14, 2021 (GLOBE NEWSWIRE) — Mesa Laboratories, Inc. (NASDAQ:MLAB) (“we”, “us”, “our”, “Mesa” or the “Company”), a global leader in the design

MADISON, WI, USA — Nimble Therapeutics, a biotechnology company revolutionizing the discovery and development of peptide therapeutics, today announced their strategic research collaboration with Incyte

MINNEAPOLIS and SALT LAKE CITY, Sept. 8, 2021 /PRNewswire/ — Bio-Techne, a leading supplier of high-quality and innovative tools for life science research, therapeutic manufacturing and clinical diagnostics and Carterra

San Diego & HILDEN, Germany & GERMAN TOWN, Md – (BUSINESS WIRE) — QIAGEN N.V. (NYSE: QGEN) (Frankfurt Prime Standard: QIA) and Verogen today announced

Marcy l’Étoile, France and Mountain View, California – June 29th, 2021 – bioMérieux, a world leader in the field of in vitro diagnostics, and Specific